Potential Side Effects: Monitoring for Adverse Reactions Monitoring for potential side effects is essential when contemplating the long-term use of GLP-1 medication for weight loss and overall health improvement
Clinical trial summaries and contemporary analyses show a broad incidence range for nauseacommonly cited as 2050% depending on dose and agentwith most episodes being mild to moderate
There are multiple drug names and mechanisms, ongoing debates about who should take the drugs, questions about cost and access, and anxiety about what happens if you stop taking them
In this situation, to the extent allowed by the efficient use of time, open-ended questions, such as, "What are your bowel movements like?" or "Have you experienced a change in your bowel movements?" are preferable
There are three iron chelators, desferrioxamine, deferiprone, and desferasirox, for the treatment of -thalassemia (Ward et al., 2015)